| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Speech Perception | 21 | 2022 | 261 | 7.170 |
Why?
|
| Hearing Loss | 10 | 2021 | 154 | 4.210 |
Why?
|
| Brain | 28 | 2022 | 2175 | 3.730 |
Why?
|
| Magnetic Resonance Imaging | 45 | 2022 | 2222 | 3.610 |
Why?
|
| Dyslexia | 8 | 2019 | 17 | 3.380 |
Why?
|
| Brain Mapping | 22 | 2022 | 531 | 2.870 |
Why?
|
| Presbycusis | 7 | 2022 | 84 | 2.560 |
Why?
|
| Noise | 9 | 2022 | 153 | 2.390 |
Why?
|
| Frontal Lobe | 11 | 2019 | 156 | 2.170 |
Why?
|
| Temporal Lobe | 10 | 2016 | 125 | 2.170 |
Why?
|
| Image Processing, Computer-Assisted | 19 | 2019 | 689 | 1.960 |
Why?
|
| Attention | 9 | 2019 | 225 | 1.820 |
Why?
|
| Aging | 12 | 2020 | 911 | 1.740 |
Why?
|
| Auditory Cortex | 7 | 2017 | 43 | 1.720 |
Why?
|
| Locus Coeruleus | 3 | 2022 | 55 | 1.710 |
Why?
|
| Cerebral Cortex | 10 | 2022 | 415 | 1.560 |
Why?
|
| Parietal Lobe | 8 | 2016 | 59 | 1.520 |
Why?
|
| Functional Laterality | 16 | 2022 | 240 | 1.470 |
Why?
|
| Visual Cortex | 4 | 2019 | 67 | 1.410 |
Why?
|
| Auditory Threshold | 9 | 2022 | 206 | 1.410 |
Why?
|
| Phonetics | 3 | 2022 | 42 | 1.400 |
Why?
|
| Williams Syndrome | 8 | 2007 | 13 | 1.400 |
Why?
|
| Pattern Recognition, Physiological | 5 | 2018 | 22 | 1.380 |
Why?
|
| Gray Matter | 2 | 2021 | 57 | 1.320 |
Why?
|
| Cognition | 11 | 2022 | 512 | 1.260 |
Why?
|
| Aged | 35 | 2022 | 14842 | 1.230 |
Why?
|
| Humans | 89 | 2022 | 68525 | 1.210 |
Why?
|
| Male | 63 | 2022 | 37281 | 1.200 |
Why?
|
| Language | 5 | 2022 | 120 | 1.200 |
Why?
|
| Middle Aged | 45 | 2022 | 21119 | 1.180 |
Why?
|
| Female | 63 | 2022 | 38015 | 1.160 |
Why?
|
| Hearing | 4 | 2022 | 133 | 1.100 |
Why?
|
| Twist-Related Protein 1 | 2 | 2017 | 13 | 1.010 |
Why?
|
| Acoustic Stimulation | 8 | 2019 | 206 | 1.000 |
Why?
|
| Vocabulary | 2 | 2016 | 14 | 0.990 |
Why?
|
| Cochlear Nerve | 2 | 2021 | 83 | 0.960 |
Why?
|
| Aged, 80 and over | 16 | 2021 | 4843 | 0.900 |
Why?
|
| Olfaction Disorders | 2 | 2022 | 100 | 0.890 |
Why?
|
| Reading | 4 | 2022 | 19 | 0.890 |
Why?
|
| Nuclear Proteins | 2 | 2017 | 271 | 0.880 |
Why?
|
| Speech | 6 | 2022 | 118 | 0.860 |
Why?
|
| Adult | 43 | 2022 | 21375 | 0.850 |
Why?
|
| Young Adult | 19 | 2022 | 5708 | 0.850 |
Why?
|
| Nasal Cavity | 2 | 2019 | 62 | 0.810 |
Why?
|
| Epilepsy, Temporal Lobe | 4 | 2010 | 138 | 0.770 |
Why?
|
| Image Enhancement | 3 | 2012 | 143 | 0.730 |
Why?
|
| Semantics | 2 | 2018 | 37 | 0.730 |
Why?
|
| Information Dissemination | 1 | 2020 | 113 | 0.690 |
Why?
|
| Corpus Callosum | 1 | 2019 | 29 | 0.680 |
Why?
|
| Lipoma | 1 | 2019 | 24 | 0.680 |
Why?
|
| Nerve Net | 5 | 2016 | 180 | 0.670 |
Why?
|
| Olfactory Mucosa | 1 | 2018 | 11 | 0.670 |
Why?
|
| Gyrus Cinguli | 6 | 2016 | 113 | 0.660 |
Why?
|
| Psycholinguistics | 1 | 2018 | 10 | 0.640 |
Why?
|
| Neoplasm Metastasis | 2 | 2017 | 306 | 0.640 |
Why?
|
| Child | 16 | 2022 | 6400 | 0.620 |
Why?
|
| Wisconsin Card Sorting Test | 1 | 2017 | 3 | 0.620 |
Why?
|
| White Matter | 2 | 2020 | 174 | 0.620 |
Why?
|
| Signal-To-Noise Ratio | 5 | 2022 | 93 | 0.620 |
Why?
|
| ADAM12 Protein | 1 | 2017 | 1 | 0.610 |
Why?
|
| Focal Adhesions | 1 | 2017 | 25 | 0.610 |
Why?
|
| Prefrontal Cortex | 4 | 2022 | 639 | 0.600 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2017 | 18 | 0.590 |
Why?
|
| Deafness | 3 | 2022 | 64 | 0.570 |
Why?
|
| Pupil | 2 | 2014 | 51 | 0.560 |
Why?
|
| Executive Function | 1 | 2017 | 106 | 0.560 |
Why?
|
| Malformations of Cortical Development | 1 | 2016 | 7 | 0.560 |
Why?
|
| Dominance, Cerebral | 4 | 2019 | 65 | 0.560 |
Why?
|
| Neuroimaging | 1 | 2017 | 122 | 0.560 |
Why?
|
| Functional Neuroimaging | 2 | 2016 | 82 | 0.550 |
Why?
|
| Visual Perception | 4 | 2017 | 124 | 0.550 |
Why?
|
| Neoplasm Invasiveness | 1 | 2017 | 369 | 0.540 |
Why?
|
| Neural Pathways | 7 | 2020 | 323 | 0.540 |
Why?
|
| Weightlessness | 3 | 2020 | 25 | 0.530 |
Why?
|
| Comprehension | 4 | 2016 | 71 | 0.530 |
Why?
|
| Age Factors | 8 | 2021 | 1860 | 0.530 |
Why?
|
| Abnormalities, Multiple | 1 | 2016 | 109 | 0.520 |
Why?
|
| Brain Neoplasms | 1 | 2019 | 371 | 0.520 |
Why?
|
| Communication | 1 | 2017 | 329 | 0.520 |
Why?
|
| Intellectual Disability | 1 | 2016 | 114 | 0.510 |
Why?
|
| Hippocampus | 4 | 2010 | 471 | 0.460 |
Why?
|
| Cerebral Small Vessel Diseases | 1 | 2013 | 10 | 0.460 |
Why?
|
| Oxygen | 4 | 2018 | 386 | 0.460 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2013 | 35 | 0.460 |
Why?
|
| Biosensing Techniques | 1 | 2013 | 51 | 0.450 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2013 | 63 | 0.440 |
Why?
|
| Nanotechnology | 1 | 2013 | 109 | 0.430 |
Why?
|
| Neovascularization, Physiologic | 1 | 2013 | 164 | 0.420 |
Why?
|
| Sound | 1 | 2011 | 16 | 0.410 |
Why?
|
| Language Tests | 1 | 2011 | 36 | 0.410 |
Why?
|
| Cell Surface Extensions | 1 | 2011 | 5 | 0.400 |
Why?
|
| Artifacts | 1 | 2012 | 125 | 0.400 |
Why?
|
| Audiometry | 4 | 2021 | 50 | 0.390 |
Why?
|
| Auditory Perception | 3 | 2020 | 89 | 0.370 |
Why?
|
| Nanoparticles | 1 | 2013 | 254 | 0.370 |
Why?
|
| Audiometry, Pure-Tone | 4 | 2019 | 96 | 0.360 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2012 | 237 | 0.360 |
Why?
|
| Psychomotor Performance | 3 | 2019 | 213 | 0.350 |
Why?
|
| Adolescent | 17 | 2022 | 8903 | 0.340 |
Why?
|
| Verbal Behavior | 2 | 2008 | 27 | 0.340 |
Why?
|
| Ethmoid Bone | 2 | 2019 | 18 | 0.330 |
Why?
|
| Language Development Disorders | 1 | 2008 | 9 | 0.320 |
Why?
|
| Diffusion Tensor Imaging | 3 | 2016 | 211 | 0.320 |
Why?
|
| Reproducibility of Results | 6 | 2018 | 2077 | 0.320 |
Why?
|
| Hearing Loss, High-Frequency | 2 | 2021 | 16 | 0.310 |
Why?
|
| Cerebellum | 4 | 2010 | 103 | 0.310 |
Why?
|
| Organ Size | 5 | 2018 | 242 | 0.300 |
Why?
|
| Brain Ischemia | 1 | 2013 | 665 | 0.300 |
Why?
|
| Perceptual Masking | 2 | 2022 | 78 | 0.290 |
Why?
|
| Cross-Sectional Studies | 3 | 2022 | 2264 | 0.280 |
Why?
|
| Smell | 3 | 2022 | 131 | 0.270 |
Why?
|
| Vision Disorders | 1 | 2006 | 94 | 0.270 |
Why?
|
| Reaction Time | 4 | 2014 | 170 | 0.270 |
Why?
|
| Case-Control Studies | 8 | 2019 | 1548 | 0.270 |
Why?
|
| Fatigue | 2 | 2016 | 132 | 0.250 |
Why?
|
| Evoked Potentials, Auditory | 2 | 2017 | 47 | 0.250 |
Why?
|
| Aptamers, Nucleotide | 2 | 2015 | 15 | 0.250 |
Why?
|
| Disability Evaluation | 2 | 2017 | 298 | 0.250 |
Why?
|
| Electroencephalography | 3 | 2022 | 418 | 0.240 |
Why?
|
| Atrophy | 5 | 2010 | 112 | 0.240 |
Why?
|
| Neoplasms | 2 | 2014 | 1660 | 0.230 |
Why?
|
| HEK293 Cells | 2 | 2017 | 326 | 0.230 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2017 | 135 | 0.230 |
Why?
|
| Alpha Rhythm | 1 | 2022 | 3 | 0.220 |
Why?
|
| Theta Rhythm | 1 | 2022 | 6 | 0.210 |
Why?
|
| Cell Movement | 2 | 2017 | 630 | 0.200 |
Why?
|
| Cognition Disorders | 4 | 2015 | 342 | 0.200 |
Why?
|
| Cell Line, Tumor | 3 | 2017 | 1849 | 0.190 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2022 | 110 | 0.190 |
Why?
|
| Hair Cells, Auditory | 1 | 2020 | 60 | 0.190 |
Why?
|
| Spatial Processing | 1 | 2020 | 4 | 0.190 |
Why?
|
| Cell Line | 2 | 2017 | 1752 | 0.180 |
Why?
|
| Stroke | 1 | 2013 | 2161 | 0.180 |
Why?
|
| Signal Transduction | 4 | 2017 | 2688 | 0.180 |
Why?
|
| Heart Diseases | 1 | 2022 | 276 | 0.180 |
Why?
|
| Astronauts | 1 | 2019 | 20 | 0.180 |
Why?
|
| Space Flight | 1 | 2019 | 40 | 0.170 |
Why?
|
| Pattern Recognition, Visual | 2 | 2017 | 69 | 0.170 |
Why?
|
| Cadaver | 2 | 2018 | 136 | 0.170 |
Why?
|
| Longitudinal Studies | 2 | 2019 | 1054 | 0.160 |
Why?
|
| Animals | 6 | 2022 | 20877 | 0.160 |
Why?
|
| Anisotropy | 2 | 2016 | 105 | 0.160 |
Why?
|
| Hearing Tests | 1 | 2017 | 70 | 0.150 |
Why?
|
| Postmortem Changes | 2 | 2015 | 15 | 0.150 |
Why?
|
| Cell Size | 1 | 2017 | 76 | 0.150 |
Why?
|
| Task Performance and Analysis | 2 | 2016 | 150 | 0.150 |
Why?
|
| Cues | 1 | 2021 | 654 | 0.150 |
Why?
|
| Protein Domains | 1 | 2017 | 74 | 0.150 |
Why?
|
| Neoplasm Transplantation | 1 | 2017 | 160 | 0.150 |
Why?
|
| Bias | 1 | 2017 | 148 | 0.150 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2017 | 204 | 0.150 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2017 | 44 | 0.150 |
Why?
|
| Memory, Short-Term | 1 | 2017 | 79 | 0.150 |
Why?
|
| Broca Area | 1 | 2016 | 5 | 0.140 |
Why?
|
| Photic Stimulation | 1 | 2017 | 229 | 0.140 |
Why?
|
| Emotions | 2 | 2017 | 244 | 0.140 |
Why?
|
| Economics, Behavioral | 1 | 2016 | 12 | 0.140 |
Why?
|
| Cerebrovascular Circulation | 1 | 2018 | 296 | 0.140 |
Why?
|
| Cell Adhesion | 1 | 2017 | 324 | 0.140 |
Why?
|
| Sensitivity and Specificity | 2 | 2012 | 1753 | 0.140 |
Why?
|
| Thalamus | 3 | 2010 | 82 | 0.130 |
Why?
|
| L-Selectin | 1 | 2015 | 28 | 0.130 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 373 | 0.130 |
Why?
|
| Brain Stem | 1 | 2015 | 46 | 0.130 |
Why?
|
| Individuality | 1 | 2015 | 44 | 0.130 |
Why?
|
| Melanins | 1 | 2015 | 24 | 0.130 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2015 | 71 | 0.130 |
Why?
|
| Coloring Agents | 1 | 2015 | 66 | 0.130 |
Why?
|
| Models, Theoretical | 1 | 2018 | 384 | 0.130 |
Why?
|
| Severity of Illness Index | 3 | 2016 | 1851 | 0.130 |
Why?
|
| Regression Analysis | 1 | 2017 | 737 | 0.130 |
Why?
|
| Breast Neoplasms | 2 | 2017 | 1533 | 0.120 |
Why?
|
| Decision Making | 1 | 2017 | 410 | 0.120 |
Why?
|
| Extracellular Matrix | 1 | 2017 | 493 | 0.120 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2020 | 239 | 0.120 |
Why?
|
| Analysis of Variance | 3 | 2011 | 1039 | 0.120 |
Why?
|
| Cluster Analysis | 2 | 2022 | 218 | 0.110 |
Why?
|
| Antibodies | 1 | 2014 | 241 | 0.110 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2013 | 82 | 0.110 |
Why?
|
| Base Sequence | 2 | 2013 | 1015 | 0.110 |
Why?
|
| Drug Carriers | 1 | 2013 | 90 | 0.110 |
Why?
|
| Leukemia | 1 | 2013 | 117 | 0.110 |
Why?
|
| Speech Intelligibility | 1 | 2012 | 14 | 0.110 |
Why?
|
| Phenotype | 4 | 2022 | 946 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 756 | 0.110 |
Why?
|
| Hearing Loss, Noise-Induced | 1 | 2013 | 46 | 0.110 |
Why?
|
| Neuropsychological Tests | 3 | 2009 | 517 | 0.110 |
Why?
|
| Retrospective Studies | 3 | 2022 | 7264 | 0.110 |
Why?
|
| Auditory Perceptual Disorders | 1 | 2012 | 4 | 0.110 |
Why?
|
| Sclerosis | 2 | 2010 | 32 | 0.110 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 1174 | 0.110 |
Why?
|
| Doxorubicin | 1 | 2013 | 231 | 0.110 |
Why?
|
| Mice | 2 | 2017 | 8472 | 0.110 |
Why?
|
| Language Disorders | 2 | 2017 | 22 | 0.110 |
Why?
|
| Space Perception | 2 | 2009 | 44 | 0.110 |
Why?
|
| Sample Size | 1 | 2012 | 79 | 0.100 |
Why?
|
| Speech Reception Threshold Test | 1 | 2011 | 25 | 0.100 |
Why?
|
| Psychoacoustics | 1 | 2011 | 33 | 0.100 |
Why?
|
| Cells, Cultured | 1 | 2017 | 2673 | 0.100 |
Why?
|
| Drug Delivery Systems | 1 | 2013 | 236 | 0.100 |
Why?
|
| Artificial Intelligence | 1 | 2013 | 159 | 0.100 |
Why?
|
| Sex Factors | 2 | 2013 | 1265 | 0.100 |
Why?
|
| DNA | 1 | 2014 | 597 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2019 | 2323 | 0.100 |
Why?
|
| src Homology Domains | 1 | 2011 | 29 | 0.100 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2011 | 17 | 0.100 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 272 | 0.100 |
Why?
|
| Child, Preschool | 2 | 2016 | 3185 | 0.100 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2011 | 62 | 0.100 |
Why?
|
| Mice, Nude | 1 | 2011 | 294 | 0.090 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2010 | 333 | 0.090 |
Why?
|
| Afferent Pathways | 1 | 2010 | 31 | 0.090 |
Why?
|
| Reference Values | 2 | 2008 | 579 | 0.090 |
Why?
|
| Forecasting | 1 | 2011 | 277 | 0.090 |
Why?
|
| RNA Interference | 1 | 2011 | 266 | 0.090 |
Why?
|
| Rhinitis | 1 | 2015 | 383 | 0.090 |
Why?
|
| Recovery of Function | 1 | 2013 | 506 | 0.090 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2007 | 144 | 0.090 |
Why?
|
| Sinusitis | 1 | 2015 | 432 | 0.090 |
Why?
|
| Occipital Lobe | 2 | 2006 | 18 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 710 | 0.090 |
Why?
|
| Biomarkers | 1 | 2015 | 1593 | 0.090 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 1465 | 0.090 |
Why?
|
| Principal Component Analysis | 1 | 2008 | 55 | 0.080 |
Why?
|
| Models, Neurological | 1 | 2009 | 136 | 0.080 |
Why?
|
| Fragile X Syndrome | 1 | 2008 | 17 | 0.080 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2008 | 20 | 0.080 |
Why?
|
| Child Behavior Disorders | 1 | 2008 | 69 | 0.080 |
Why?
|
| ROC Curve | 1 | 2008 | 392 | 0.080 |
Why?
|
| Autistic Disorder | 1 | 2008 | 77 | 0.070 |
Why?
|
| Risk Assessment | 1 | 2013 | 2004 | 0.070 |
Why?
|
| Fractals | 1 | 2006 | 5 | 0.070 |
Why?
|
| Turner Syndrome | 1 | 2006 | 10 | 0.070 |
Why?
|
| Discrimination Learning | 1 | 2006 | 45 | 0.070 |
Why?
|
| Sensation Disorders | 1 | 2006 | 14 | 0.070 |
Why?
|
| Neostriatum | 1 | 2006 | 60 | 0.070 |
Why?
|
| Orbit | 1 | 2006 | 30 | 0.070 |
Why?
|
| Mesencephalon | 1 | 2006 | 41 | 0.070 |
Why?
|
| Hypothalamus | 1 | 2006 | 78 | 0.070 |
Why?
|
| Movement Disorders | 1 | 2006 | 58 | 0.070 |
Why?
|
| Algorithms | 1 | 2012 | 1194 | 0.070 |
Why?
|
| Sex Characteristics | 1 | 2008 | 295 | 0.070 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 2550 | 0.070 |
Why?
|
| Cohort Studies | 2 | 2017 | 2356 | 0.070 |
Why?
|
| Social Behavior | 1 | 2006 | 164 | 0.070 |
Why?
|
| Jurkat Cells | 2 | 2015 | 59 | 0.060 |
Why?
|
| Schizophrenia | 1 | 2006 | 206 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2008 | 785 | 0.060 |
Why?
|
| Surveys and Questionnaires | 2 | 2015 | 2798 | 0.060 |
Why?
|
| Tongue | 1 | 2003 | 20 | 0.060 |
Why?
|
| Cephalometry | 1 | 2003 | 19 | 0.060 |
Why?
|
| Mutation | 1 | 2008 | 1213 | 0.050 |
Why?
|
| Hair Cells, Auditory, Outer | 1 | 2022 | 33 | 0.050 |
Why?
|
| Gerbillinae | 1 | 2022 | 156 | 0.050 |
Why?
|
| Neuronal Plasticity | 1 | 2005 | 274 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2015 | 3702 | 0.050 |
Why?
|
| Psychometrics | 1 | 2003 | 514 | 0.050 |
Why?
|
| Multivariate Analysis | 1 | 2003 | 1046 | 0.040 |
Why?
|
| Eye Diseases | 1 | 2019 | 38 | 0.040 |
Why?
|
| Sensory Thresholds | 1 | 2019 | 50 | 0.040 |
Why?
|
| Logistic Models | 1 | 2003 | 1419 | 0.040 |
Why?
|
| Dissection | 1 | 2018 | 29 | 0.040 |
Why?
|
| Skull Base | 1 | 2018 | 72 | 0.040 |
Why?
|
| Oscillometry | 1 | 2017 | 5 | 0.040 |
Why?
|
| Magnetoencephalography | 1 | 2017 | 6 | 0.040 |
Why?
|
| Bone Density | 1 | 2018 | 159 | 0.040 |
Why?
|
| Time Factors | 2 | 2019 | 4655 | 0.040 |
Why?
|
| Discriminant Analysis | 1 | 2016 | 36 | 0.040 |
Why?
|
| Electrodes | 1 | 2017 | 147 | 0.040 |
Why?
|
| Quality of Life | 1 | 2022 | 1515 | 0.030 |
Why?
|
| Ligands | 1 | 2014 | 317 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 2014 | 248 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2014 | 852 | 0.030 |
Why?
|
| Protein Binding | 1 | 2015 | 1027 | 0.030 |
Why?
|
| Cell Survival | 1 | 2013 | 901 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2015 | 1329 | 0.020 |
Why?
|
| Parahippocampal Gyrus | 1 | 2010 | 15 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2013 | 621 | 0.020 |
Why?
|
| Putamen | 1 | 2010 | 35 | 0.020 |
Why?
|
| Signal Detection, Psychological | 1 | 2009 | 21 | 0.020 |
Why?
|
| Nerve Fibers | 1 | 2010 | 77 | 0.020 |
Why?
|
| Limbic System | 1 | 2010 | 106 | 0.020 |
Why?
|
| Workload | 1 | 2009 | 103 | 0.020 |
Why?
|
| Amygdala | 1 | 2010 | 159 | 0.020 |
Why?
|
| Caudate Nucleus | 1 | 2008 | 56 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2008 | 89 | 0.020 |
Why?
|
| Wechsler Scales | 1 | 2007 | 15 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2008 | 159 | 0.020 |
Why?
|
| Hyperacusis | 1 | 2007 | 2 | 0.020 |
Why?
|
| Histone Deacetylases | 1 | 2008 | 99 | 0.020 |
Why?
|
| Apoptosis | 1 | 2014 | 1640 | 0.020 |
Why?
|
| Matched-Pair Analysis | 1 | 2006 | 25 | 0.020 |
Why?
|
| Internal Capsule | 1 | 2006 | 7 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2008 | 159 | 0.020 |
Why?
|
| ErbB Receptors | 1 | 2008 | 239 | 0.020 |
Why?
|
| Neural Inhibition | 1 | 2006 | 80 | 0.020 |
Why?
|
| Genome | 1 | 2006 | 54 | 0.020 |
Why?
|
| Genotype | 1 | 2008 | 785 | 0.020 |
Why?
|
| Mathematics | 1 | 2005 | 83 | 0.020 |
Why?
|
| Intelligence Tests | 1 | 2004 | 32 | 0.020 |
Why?
|
| Face | 1 | 2004 | 46 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2005 | 189 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2005 | 438 | 0.010 |
Why?
|
| Infant | 1 | 2008 | 2891 | 0.010 |
Why?
|
| Rats | 1 | 2008 | 5300 | 0.010 |
Why?
|